Matthew Machin, Sarah Whittley, John Norrie, Laura Burgess, Beverley J Hunt, Layla Bolton, Joseph Shalhoub, Tamara Everington, Manjit Gohel, Mark S Whiteley, Steven Rogers, Sarah Onida, Benedict Turner, Sandip Nandhra, Rebecca Lawton, Annya Stephens-Boal, Carolyn Singer, Joanne Dunbar, Daniel Carradice, A H Davies
INTRODUCTION: Endovenous therapy is the first choice management for symptomatic varicose veins in NICE guidelines, with 56-70 000 procedures performed annually in the UK. Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a known complication of endovenous therapy, occurring at a rate of up to 3.4%. Despite 73% of UK practitioners administering pharmacological thromboprophylaxis to reduce VTE, no high-quality evidence supporting this practice exists...
February 17, 2024: BMJ Open